Handbook of Cell and Gene Therapy (eBook, ePUB)
From Proof-of-Concept through Manufacturing to Commercialization
Redaktion: Aranha, Hazel; Vega-Mercado, Humberto
48,95 €
48,95 €
inkl. MwSt.
Sofort per Download lieferbar
24 °P sammeln
48,95 €
Als Download kaufen
48,95 €
inkl. MwSt.
Sofort per Download lieferbar
24 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
48,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
24 °P sammeln
Handbook of Cell and Gene Therapy (eBook, ePUB)
From Proof-of-Concept through Manufacturing to Commercialization
Redaktion: Aranha, Hazel; Vega-Mercado, Humberto
- Format: ePub
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
This book is intended as a one-stop resource for availability of state-of-the-art information related to cell and gene therapy products for researchers, scientists, management and other academic and research institutions working in the field.
- Geräte: eReader
- ohne Kopierschutz
- eBook Hilfe
- Größe: 8.81MB
Andere Kunden interessierten sich auch für
- Handbook of Cell and Gene Therapy (eBook, PDF)48,95 €
- Antimicrobial Photodynamic Therapy (eBook, ePUB)51,95 €
- Handbook of Proteases in Cancer (eBook, ePUB)174,95 €
- Handbook of Proteases in Cancer (eBook, ePUB)174,95 €
- Gene and Cell Therapy (eBook, ePUB)307,95 €
- Handbook of Analysis of Oligonucleotides and Related Products (eBook, ePUB)82,95 €
- Molecular Pathomechanisms and New Trends in Drug Research (eBook, ePUB)60,95 €
-
-
-
This book is intended as a one-stop resource for availability of state-of-the-art information related to cell and gene therapy products for researchers, scientists, management and other academic and research institutions working in the field.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis
- Seitenzahl: 372
- Erscheinungstermin: 17. März 2023
- Englisch
- ISBN-13: 9781000864250
- Artikelnr.: 67419422
- Verlag: Taylor & Francis
- Seitenzahl: 372
- Erscheinungstermin: 17. März 2023
- Englisch
- ISBN-13: 9781000864250
- Artikelnr.: 67419422
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
History of Gene Therapy Products
Overview of technologies applied to gene therapy products
History of Cell Therapy Products
Overview of technologies applied to cell therapy products - what it entails
Gene Therapy Manufacturing- an Overview on Viral Vectors and Plasmid Manufacturing, Does it suffice
Basic considerations - Manufacturing Processes: - Cell therapy products
Analytical Methods
Facility and equipment considerations
Control of adventitious agent contamination during manufacture of cell and gene therapy products
Quality Considerations from Clinical to Commercial Manufacturing
Regulatory Compliance and Approval
CMC Submissions
Validation, Verification and Qualification Considerations
Clinical development of cell and gene therapies -from first-in-human to postmarketing studies
Risk-based approach in the development of cell and gene therapy products
Current global regulatory landscape
Comparison of EU and US Regulatory Requirements
Regulatory Landscape for Gene and Cell Therapies
Canada
China
Regulation of cell product and gene therapy
South Asia Countries
Japan
Regulatory Pathway for Cell, Tissue and Gene Therapy Products in Singapore
Regulatory Pathway for Cell and Gene Therapy Products in Malaysia
The Regulation of Cell and Gene Therapy Products in Australia and New Zealand
Pricing and market access: the market access hurdle
Training Approaches to Build Cell and Gene Therapy Workforce Capacity
Lessons Learned - Successes and Pitfalls
Pitfall Avoidance through Cross-Functional Development Approach
Overview of technologies applied to gene therapy products
History of Cell Therapy Products
Overview of technologies applied to cell therapy products - what it entails
Gene Therapy Manufacturing- an Overview on Viral Vectors and Plasmid Manufacturing, Does it suffice
Basic considerations - Manufacturing Processes: - Cell therapy products
Analytical Methods
Facility and equipment considerations
Control of adventitious agent contamination during manufacture of cell and gene therapy products
Quality Considerations from Clinical to Commercial Manufacturing
Regulatory Compliance and Approval
CMC Submissions
Validation, Verification and Qualification Considerations
Clinical development of cell and gene therapies -from first-in-human to postmarketing studies
Risk-based approach in the development of cell and gene therapy products
Current global regulatory landscape
Comparison of EU and US Regulatory Requirements
Regulatory Landscape for Gene and Cell Therapies
Canada
China
Regulation of cell product and gene therapy
South Asia Countries
Japan
Regulatory Pathway for Cell, Tissue and Gene Therapy Products in Singapore
Regulatory Pathway for Cell and Gene Therapy Products in Malaysia
The Regulation of Cell and Gene Therapy Products in Australia and New Zealand
Pricing and market access: the market access hurdle
Training Approaches to Build Cell and Gene Therapy Workforce Capacity
Lessons Learned - Successes and Pitfalls
Pitfall Avoidance through Cross-Functional Development Approach
History of Gene Therapy Products
Overview of technologies applied to gene therapy products
History of Cell Therapy Products
Overview of technologies applied to cell therapy products - what it entails
Gene Therapy Manufacturing- an Overview on Viral Vectors and Plasmid Manufacturing, Does it suffice
Basic considerations - Manufacturing Processes: - Cell therapy products
Analytical Methods
Facility and equipment considerations
Control of adventitious agent contamination during manufacture of cell and gene therapy products
Quality Considerations from Clinical to Commercial Manufacturing
Regulatory Compliance and Approval
CMC Submissions
Validation, Verification and Qualification Considerations
Clinical development of cell and gene therapies -from first-in-human to postmarketing studies
Risk-based approach in the development of cell and gene therapy products
Current global regulatory landscape
Comparison of EU and US Regulatory Requirements
Regulatory Landscape for Gene and Cell Therapies
Canada
China
Regulation of cell product and gene therapy
South Asia Countries
Japan
Regulatory Pathway for Cell, Tissue and Gene Therapy Products in Singapore
Regulatory Pathway for Cell and Gene Therapy Products in Malaysia
The Regulation of Cell and Gene Therapy Products in Australia and New Zealand
Pricing and market access: the market access hurdle
Training Approaches to Build Cell and Gene Therapy Workforce Capacity
Lessons Learned - Successes and Pitfalls
Pitfall Avoidance through Cross-Functional Development Approach
Overview of technologies applied to gene therapy products
History of Cell Therapy Products
Overview of technologies applied to cell therapy products - what it entails
Gene Therapy Manufacturing- an Overview on Viral Vectors and Plasmid Manufacturing, Does it suffice
Basic considerations - Manufacturing Processes: - Cell therapy products
Analytical Methods
Facility and equipment considerations
Control of adventitious agent contamination during manufacture of cell and gene therapy products
Quality Considerations from Clinical to Commercial Manufacturing
Regulatory Compliance and Approval
CMC Submissions
Validation, Verification and Qualification Considerations
Clinical development of cell and gene therapies -from first-in-human to postmarketing studies
Risk-based approach in the development of cell and gene therapy products
Current global regulatory landscape
Comparison of EU and US Regulatory Requirements
Regulatory Landscape for Gene and Cell Therapies
Canada
China
Regulation of cell product and gene therapy
South Asia Countries
Japan
Regulatory Pathway for Cell, Tissue and Gene Therapy Products in Singapore
Regulatory Pathway for Cell and Gene Therapy Products in Malaysia
The Regulation of Cell and Gene Therapy Products in Australia and New Zealand
Pricing and market access: the market access hurdle
Training Approaches to Build Cell and Gene Therapy Workforce Capacity
Lessons Learned - Successes and Pitfalls
Pitfall Avoidance through Cross-Functional Development Approach